Future Talk | Episode 22 | SYNTHIA™ | Merck KGaA, Darmstadt, Germany

Dead ends are all too common in new drug development. The AI-powered chemical synthesis software Synthia™ could change that. ⚛️ Tune into Future Talk Podcast as our experts Sarah Trice & Prof. Timothy Cernak discuss the future of Retrosynthesis. #alwayscurious